Saturday, 29 April 2017

Japan News

  • Japan's Astellas pharma to acquire Belgium firm Ogeda

    Japan |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: If reports are to be believed, Japan's Astellas pharma is all set to acquire Belgium's clinical-stage drug discovery firm Ogeda for around €800m. Ogeda is engaged in the di...Read more

  • Takeda off-loads some drug development to JV

    Japan |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: In a bid to concentrate resources on the core focus areas, Japanese drug giant Takeda Pharmaceutical has formed a 10 billion yen ($87.2 million) drug development company with two...Read more

  • Lupin inks pact to distribute antidepressant drug in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: India based drug giant Lupin pharmaceuticals Japanese subsidiary Kyowa recently inked a pact with Japan's Astellas pharma seeking exclusive rights to distribute and promote exten...Read more

  • Daiichi Sankyo closes its Japanese research subsidiary

    Japan |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Daiichi Sankyo recently announced its plans to close its Japanese research subsidiary Asubio Pharma that focuses research primarily on psychiatric and neurological diseases, immu...Read more

  • Japan's Takeda to invest €40 million in Irish facility

    Japan |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Japanese drug giant Takeda is planning to invest nearly €40 million in a new facility in Dublin in a move that will lead to the creation of 40 jobs. The company first inves...Read more

  • Sanofi to launch 20 new drugs in Japan by 2020

    Japan |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: If reports are to be believed French drug giant Sanofi is all set to launch 20 new drugs in Japan by 2020. In a recently held press meet the company's CEO Mr Jacques Nathan said ...Read more

  • Japan's Fujifilm Holdings to acquire Takeda's arm?

    Japan |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: If sources are to be believed, Japan's Fujifilm Holdings is all set to buy pharma giant Takeda Pharmaceutical's 70 percent stake in Wako Pure Chemical Industries for about 200 bi...Read more

  • Japanese firm invests $11.4 mn in TB and malaria research

    Japan |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: With a view to curb the menace of malaria and tuberculosis(TB), Japan's investment firm, Global Health Innovative Technology Fund (GHIT Fund) has issued funding totaling $11.4 mi...Read more

  • Cardinal Health expands cardiovascular portfolio

    Japan |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Cardinal Health has expanded its current distribution agreement with Biosensors as the exclusive distributor for Biosensors' coronary interventional products in Japan. The co...Read more

  • Clinigen makes foray into Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Further building on its presence in the Asian region, Burton-based Clinigen Group,has launched its Japanese business with the opening of an office in Tokyo, Japan. Alongside the ...Read more

  • Japan's Towa Phamaceuticals to enter the US market

    Japan |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Japanese drug giant Towa Pharmaceuticals makes foray into the US markets banking on its new set of pills that can be taken without water. The tablets, manufactured with Ractab te...Read more

  • India urges Japan to provide wider pharma market access

    Japan |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The Indian commerce Minister, Ms Nirmala Sitharaman has urged Japan to provide Indian pharmaceutical sector with a wider share and greater market access in Japan. Ms Sitharaman f...Read more

  • Zydus Cadila, Takeda to co-develop vaccine for chikungunya

    Japan |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Japan's Takeda pharmaceuticals has joined hands with India-based Zydus Cadila in an aim to co-develop a vaccine for chikungunya. As per the terms the companies will jointly devel...Read more

  • Japan market forecast

    Japan |  Opinion | By BioSpectrum Bureau | 0 Comment

    Singapore: Japan's demographic profile will continue to create revenue earning opportunities for the pharmaceuticals and healthcare industry. Supported by an expansive universal healthcare ...Read more

  • Stem cell scientist sues Nobel laureate for deception

    Japan |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Dr Rongxiang Xu, a scientist who claims to be the founder of human body regenerative restoration science, has filed a lawsuit against Dr Shinya Yamanaka, one of the winners of th...Read more

  • Niigata Univ stroke therapy license for Shimojani

    Japan |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Shimojani obtained exclusive license from Japan's Niigata University for worldwide development and commercialization of an invention that reduces the risk of hemorrhage in acu...Read more

  • Astellas prostrate cancer drug gets EU nod

    Japan |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The European Commission has approved Xtandi (enzalutamide) capsules for the treatment of men with metastatic castration-resistant prostate cancer, whose disease has progressed on...Read more

  • Columbia Asia receives $101mn investment from Mitsui & Co.

    Japan |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Columbia Asia has announced it is receiving $101 million in investment from Mitsui & Co., Ltd. Columbia Asia, part of Seattle-based Columbia Pacific Management, has 27 hospi...Read more

Survey Box

Is point-of-care the hottest trend in medical devices?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls